Skip to main content
. 2025 Sep 9;13(18):2258. doi: 10.3390/healthcare13182258
EC European Commission
EMA European Medicines Agency
EU European Union
GDP Gross domestic product
HTA Health technology assessment
MA Marketing authorization
NHIF National Health Insurance Fund
NCPRMP National Council on Prices and Reimbursement of Medicinal Products
ODDs Orphan-designated drugs
PDL Positive drug list
RWE Real-world evidence